ABEO holder plans sale of 12,606 common shares

Madhav Vasanthavada has notified plans to sell 12,606 shares of common stock through Stifel Nicolaus & Company on 07/09/2026 on Nasdaq, with an aggregate market value of $87,784.00.

Accepted by SEC EDGAR 07/09/2026 - 04:15 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Madhav Vasanthavada has notified plans to sell 12,606 shares of common stock through Stifel Nicolaus & Company on 07/09/2026 on Nasdaq, with an aggregate market value of $87,784.00. These shares relate to restricted stock awards acquired from the issuer on 07/08/2026, alongside prior common stock sales over the past three months.

Key Figures

Planned shares to be sold: 12,606 shares Aggregate market value of planned sale: $87,784.00 Restricted stock awards acquired: 28,519 shares +3 more

6 metrics

Planned shares to be sold 12,606 shares Common stock sale planned for 07/09/2026 on Nasdaq

Aggregate market value of planned sale $87,784.00 Total value of 12,606 shares of common stock

Restricted stock awards acquired 28,519 shares Common stock acquired on 07/08/2026 as equity compensation

Sale on 05/11/2026 5,548 shares for $33,073.00 Common stock sold by Madhav Vasanthavada during past three months

Sale on 06/08/2026 4,170 shares for $22,641.00 Common stock sold by Madhav Vasanthavada during past three months

Sale on 06/09/2026 5,450 shares for $28,908.00 Common stock sold by Madhav Vasanthavada during past three months

Key Terms

Restricted Stock Awards, Equity Compensation, Form 144

3 terms

Restricted Stock Awards financial

"Common Stock | 07/08/2026 | Restricted Stock Awards | Issuer"

Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.

Equity Compensation financial

"07/08/2026 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is disclosed for ABEO in this Form 144 content?

The content shows Madhav Vasanthavada planning to sell 12,606 shares of ABEO common stock on 07/09/2026 through Stifel Nicolaus & Company on Nasdaq, for an aggregate market value of $87,784.00.

How many ABEO shares did Madhav Vasanthavada acquire as restricted stock awards?

Madhav Vasanthavada acquired 28,519 shares of ABEO common stock on 07/08/2026 as Restricted Stock Awards from the issuer, categorized as Equity Compensation in the disclosure.

What ABEO stock sales have occurred in the past three months for this holder?

Over the past three months, Madhav Vasanthavada sold ABEO common stock in three transactions: 5,548 shares for $33,073.00 on 05/11/2026, 4,170 shares for $22,641.00 on 06/08/2026, and 5,450 shares for $28,908.00 on 06/09/2026.

Which broker is handling the planned ABEO stock sale for Madhav Vasanthavada?

The planned sale of 12,606 shares of ABEO common stock is to be handled by Stifel Nicolaus & Company Inc., located at 501 N Broadway, St. Louis, MO 63102.

On which market will the planned 12,606-share ABEO sale take place?

The planned sale of 12,606 ABEO common shares with an aggregate market value of $87,784.00 is listed to occur on the Nasdaq market on 07/09/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002106295
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ABEONA THERAPEUTICS INC.
SEC File Number	001-15771
Address of Issuer	6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OHIO 44103
Phone	646-813-4701
Name of Person for Whose Account the Securities are To Be Sold	Vasanthavada Madhav
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	12606	87784.00	56995144	07/09/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/08/2026	Restricted Stock Awards	Issuer			28519	07/08/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Madhav Vasanthavada 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103	Common Stock	05/11/2026	5548	33073.00
Madhav Vasanthavada 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103	Common Stock	06/08/2026	4170	22641.00
Madhav Vasanthavada 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103	Common Stock	06/09/2026	5450	28908.00

144: Remarks and Signature

Remarks	These shares were sold to cover for taxes pursuant to an RSA vesting event.
Date of Notice	07/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Weimer, as a duly authorized representative of STIFEL, as attorney-in-fact for Madhav Vasanthavada
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)